



• Preparation of Cannabinoid and NO formulation 
serial dilutions. 
RayBio COVID-19 Spike-ACE2 binding assay kit is 
an in vitro enzyme-linked immunosorbent assay
Conclusions
• A dose dependent response characteristic of 
phytocannabinoids is confirmed here with only the 
20mM and 2mM concentrations significantly 
reducing the perceived binding of ACE2 and SARS-
CoV-2 spike protein.
• Nitric oxide or its derivatives tend to act on a 
systems level, effecting receptors and stimulating 
biochemical pathways that our assay kit lacks. 
• We hypothesize that the more robust systems of 
cells and tissues, like 3D tissue models, will be able 
to handle the pH of the NO and thus also produce a 
stimulatory effect due to the damaged cells. 
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Introduction
• SARS-CoV-2 spike protein binding to ACE2 
receptor on human cells is the critical step in entry. 
Thus, identification of small molecules, antibodies, 
or other biological molecules that interfere with the 
formation of the S-ACE2 complex, could help to 
develop drugs to prevent or treat COVID-19(1). 
• High-CBD Cannabis has modulated ACE2 gene 
expression in human tissues, but it is unclear if 
these cannabimimetic molecules directly interact 
with the S-ACE2 binding or if it is solely due to the 
cannabinoid receptor mediated affects(2).
• Additionally, NO likely causes conformational 
changes on surface glycoproteins that can interfere 
with host cell fusion, preventing infection and 
release of virions from already infected host cells(3).
Results
Preliminary ELISA, (CBD, CBG, Ramipril, Nitric 
Oxide)
• High dose CBG and CBD appear to show a 40% 
reduction in optical density, implying a dose 
dependence. 
• Ramipril formed precipitate showing no change to 
optical density. 
• Nitric oxide appeared to have no effect at all 
concentrations.
Goals
1.Determine if cannabinoids and terpenes can 
interfere directly with the S-ACE2 binding, 
independent of cannabinoid receptors. 
2.Determine if NO interferes directly with the RBD 
of the Spike protein. 
Future Research
• Using human derived 3D tissue models of oral, 
airway, and intestinal tissues, will enable us to more 
closely recreate an accurate system that can 
withstand the irritation of both the NO and 
Cannabis.
• Understanding how each, the expression changes 
and the direct binding interference, can lead to more 
refined experimentation with both products. 
• Along with ACE2, serine protease TMPRSS2 plays 
an important role in the SARS-CoV-2 infection 
process, so using an experimental model that 
incorporates the genetic expression of complex 
tissues is imperative. 
• Advanced formulations of rare cannabinoids and 
terpenes need further elucidation and due to the long 
period of prohibition, the experimental and 
particularly clinical trials with complex mixtures of 
this kind are completely missing from the literature. 
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Figure 1. Optical Density of CBD preliminary ELISA (n=10) 
• Indicating that the CBD and CBG reduced the S-
ACE2 complex from forming, but only at the highest 
doses.
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